Clodronate or clodronic acid
- Level
- Commodity
- Parent
- 51182400
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51182427This classification denotes a bone resorption inhibitor and biphosphonate with the molecular formula CH4Cl2O6P2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0813BZ6866, chemically known as 2-chloro-5-(2,3-dihydro-1-hydroxy-3-oxo-1h-isoindol-1-yl)benzenesulfonamide but generally known as clodronic acid, which bears US NIH Compound Identifier 2732. European Medicines Agency schedules Clodronic acid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06693MIG. The term CLODRONIC ACID is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 31, No10, 1977, List 17). World Health Organization schedules clodronic acid in its Anatomical Therapeutic Chemical (ATC) Classification. Clodronate or clodronic acid bears US NLM identifiers UMLS ID C0012081 and NCI Concept Code C61685. SMILES: Clc1c(S(=O)(=O)N)cc(C2(O)NC(=O)c3c2cccc3)cc1.
Same parent
Under 51182400 · 28Activities that produce or sell this
KBLI · 8Inherited from family 51180000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.